ITCI stock steadies as investors watch fresh results

Published on 09/04/2026 at 19:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ITCI stock keeps investors on the latest reported figures, with the next catalyst centered on the most recent quarter, market valuation and the upcoming earnings date.

ITCI, US46116X1019, Illustration mit AI erstellt.

Intracellular Therapies (US46116X1019) stock is trading with fresh market attention on September 4, 2026, while investors weigh the latest reported quarter, the share valuation and the next earnings date.

Market level and valuation

ITCI stock is a Nasdaq name, so the relevant price, volume and market value need to be read in USD terms on the U.S. venue. That market frame matters because the share price and market capitalization together set the tone for how much of the current story is already priced in.

The key figures are the current quote, the daily move and the 52-week range, all of which define the stock position before any new operating update lands. For a biotech stock, that range often matters more than a single session.

Latest reported quarter

The most recent reported fundamentals remain the real anchor: revenue, earnings per share and guidance from the latest quarter shape the current debate around Intracellular Therapies. These are the numbers that matter for ITCI stock, not just the headline move of the day.

For context, the article set used in this call does not deliver a fresh company release with the exact revenue and EPS values visible in the search snippets, so the current market read has to lean more heavily on the trading data and the next scheduled reporting date. That keeps the focus on what is actually visible and dated.

Go deeper

ITCI investor material

Open the company area for the next reporting items and corporate updates.

Company page Investor Relations

Representative product

Intracellular Therapies built its business around central nervous system therapies, with Caplyta as the best-known product in the portfolio. For investors, the product mix matters because sales concentration can move the whole valuation quickly when the next set of numbers arrives.

Trading snapshot

ITCI stock closes the day with the Nasdaq market lens in USD, and the stock is best read against the latest quote, market capitalization and 52-week range on the same date. That combination gives the cleanest view of where the shares stand as of September 4, 2026.